Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216732 · ClinicalTrials.gov registry record
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
A clinical trial of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,030
- Enrollment target
- 2
- Study locations
NCT04216732 is a study of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,030 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04216732, a study of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,030 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Blood Pressure Measurement
Study Locations (2)
California
- University of California San Francisco - San Francisco
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,030 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2026-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04216732
The ClinicalTrials.gov registry entry for NCT04216732 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04216732 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT04216732 about?
NCT04216732 is a clinical study titled "Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management". This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn ab...
What is the current status of trial NCT04216732?
This trial is currently recruiting. The enrollment target is 2,030 participants. The study started on 2020-01-10. Estimated completion is 2026-09-01.
What conditions does trial NCT04216732 study?
This clinical trial studies the following conditions: Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8, Advanced Thyroid Gland Medullary Carcinoma.
What interventions are being tested in trial NCT04216732?
The interventions under investigation include: Questionnaire Administration (OTHER), Blood Pressure Measurement (OTHER).
Who is sponsoring clinical trial NCT04216732?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04216732 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
All registered trials for this condition
Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.